Literature DB >> 19414353

Characterization of phosphodiesterase 1 in human malignant melanoma cell lines.

Kasumi Shimizu1, Taku Murata, Yoshihiro Watanabe, Chu Sato, Hiroshi Morita, Toshiro Tagawa.   

Abstract

BACKGROUND: Differentiation-inducing factor 1 [DIF-1; 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl) hexan-1-one] from Dictyostelium discoideum exhibits antiproliferative activity in mammalian cells. We have previously shown that phosphodiesterase 1 (PDE1) is a pharmacological target of DIF-1, but there are no reports of PDE1 in human malignant melanoma cells. Therefore, we characterized PDE1 in human malignant melanoma MAA cells.
MATERIALS AND METHODS: PDE1 mRNA expression was investigated in MAA cells. The full open reading frames for human PDE1C1 and PDE1C3 were cloned. Cell growth was determined by MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt] assay.
RESULTS: PDE1C mRNA expression was detected in MAA cells. The nucleotide sequence of PDE1C1 was identical to that of human PDE1C1, previously published. At nucleotide 2246 in PDE1C3, A was replaced by G, but this did not change the encoded amino acid. Cell growth was inhibited by the PDE1 inhibitor vinpocetin.
CONCLUSION: PDE1C mRNA is expressed and may play an important role in human malignant melanoma MAA cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19414353

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

Review 1.  Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment.

Authors:  Isaac Levy; Anelia Horvath; Monalisa Azevedo; Rodrigo Bertollo de Alexandre; Constantine A Stratakis
Journal:  Curr Opin Pharmacol       Date:  2011-10-31       Impact factor: 5.547

2.  Multiprotein Complex With TRPC (Transient Receptor Potential-Canonical) Channel, PDE1C (Phosphodiesterase 1C), and A2R (Adenosine A2 Receptor) Plays a Critical Role in Regulating Cardiomyocyte cAMP and Survival.

Authors:  Yishuai Zhang; Walter Knight; Si Chen; Amy Mohan; Chen Yan
Journal:  Circulation       Date:  2018-10-30       Impact factor: 29.690

Review 3.  Clinical and molecular genetics of the phosphodiesterases (PDEs).

Authors:  Monalisa F Azevedo; Fabio R Faucz; Eirini Bimpaki; Anelia Horvath; Isaac Levy; Rodrigo B de Alexandre; Faiyaz Ahmad; Vincent Manganiello; Constantine A Stratakis
Journal:  Endocr Rev       Date:  2013-12-05       Impact factor: 19.871

4.  RAF-isotype switching: from B to C through PDE.

Authors:  Eric Lau; Ze'ev Ronai
Journal:  Nat Struct Mol Biol       Date:  2011-05       Impact factor: 15.369

5.  Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia.

Authors:  Yujun Cai; David J Nagel; Qian Zhou; Katherine D Cygnar; Haiqing Zhao; Faqian Li; Xinchun Pi; Peter A Knight; Chen Yan
Journal:  Circ Res       Date:  2015-01-21       Impact factor: 17.367

6.  Naringenin enhances anti-proliferation effect of 1-ferrocenyl-3-(4-methylsulfonylphenyl) propen-1-one on two different cells via targeting calmodulin signaling pathway.

Authors:  Sadegh Rajabi; Shokoofe Noori; Mohammad Reza Ashrafi; Mahsa Azami Movahed; Shabnam Farzaneh; Afshin Zarghi
Journal:  Mol Biol Rep       Date:  2022-01-14       Impact factor: 2.316

Review 7.  Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.

Authors:  F Ahmad; T Murata; K Shimizu; E Degerman; D Maurice; V Manganiello
Journal:  Oral Dis       Date:  2014-09-12       Impact factor: 3.511

Review 8.  Role of phosphodiesterase 1 in the pathophysiology of diseases and potential therapeutic opportunities.

Authors:  Arun Samidurai; Lei Xi; Anindita Das; Audra N Iness; Navin G Vigneshwar; Pin-Lan Li; Dinender K Singla; Sakthivel Muniyan; Surinder K Batra; Rakesh C Kukreja
Journal:  Pharmacol Ther       Date:  2021-04-22       Impact factor: 13.400

9.  MicroRNA-133 Targets Phosphodiesterase 1C in Drosophila and Human Oral Cancer Cells to Regulate Epithelial-Mesenchymal Transition.

Authors:  Ji Eun Jung; Joo Young Lee; Hae Ryoun Park; Ji Wan Kang; Yun Hak Kim; Ji Hye Lee
Journal:  J Cancer       Date:  2021-07-03       Impact factor: 4.207

10.  Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells.

Authors:  Hiroshi Morita; Taku Murata; Kasumi Shimizu; Kenya Okumura; Madoka Inui; Toshiro Tagawa
Journal:  Oncol Rep       Date:  2013-01-31       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.